NCT00344955View on ClinicalTrials.gov

Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

Healthy

Interventions

DRUG

HMG-CoA reductase inhibition (atorvastatin)

Trial Locations (1)

7500

Medical Research, Holstebro

All Listed Sponsors

lead

Regional Hospital Holstebro

OTHER

NCT00344955 - Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects | Biotech Hunter | Biotech Hunter